Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1174

1.

The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study.

Kwan HY, Maddocks M, Nolan CM, Jones SE, Patel S, Barker RE, Kon SSC, Polkey MI, Cullinan P, Man WD.

J Cachexia Sarcopenia Muscle. 2019 Jun 17. doi: 10.1002/jcsm.12463. [Epub ahead of print]

PMID:
31207189
2.

Patterns and features of methamphetamine-related presentations to emergency departments in QLD from 2005 to 2017.

Jones R, Woods C, Barker R, Usher K.

Int J Ment Health Nurs. 2019 Jun 9. doi: 10.1111/inm.12618. [Epub ahead of print]

PMID:
31179592
3.

Neuropathy-related mutations alter the membrane binding properties of the human myelin protein P0 cytoplasmic tail.

Raasakka A, Ruskamo S, Barker R, Krokengen OC, Vatne GH, Kristiansen CK, Hallin EI, Skoda MWA, Bergmann U, Wacklin-Knecht H, Jones NC, Hoffmann SV, Kursula P.

PLoS One. 2019 Jun 7;14(6):e0216833. doi: 10.1371/journal.pone.0216833. eCollection 2019.

4.

Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway.

Stott SRW, Randle SJ, Al Rawi S, Rowicka P, Harris R, Mason B, Xia J, Dalley JW, Barker RA, Laman H.

J Pathol. 2019 May 29. doi: 10.1002/path.5312. [Epub ahead of print]

PMID:
31144295
5.

The relation between brain signal complexity and task difficulty on an executive function task.

Grundy JG, Barker RM, Anderson JAE, Shedden JM.

Neuroimage. 2019 May 18;198:104-113. doi: 10.1016/j.neuroimage.2019.05.045. [Epub ahead of print]

PMID:
31112787
6.

Processing differences between monolingual and bilingual young adults on an emotion n-back task.

Barker RM, Bialystok E.

Brain Cogn. 2019 Aug;134:29-43. doi: 10.1016/j.bandc.2019.05.004. Epub 2019 May 17.

PMID:
31108367
7.

L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.

Malek N, Kanavou S, Lawton MA, Pitz V, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Williams NM, Wood N, Morris HR, Grosset DG; PRoBaND clinical consortium.

Parkinsonism Relat Disord. 2019 May 14. pii: S1353-8020(19)30243-3. doi: 10.1016/j.parkreldis.2019.05.022. [Epub ahead of print]

PMID:
31105012
8.

Targeting Huntingtin Expression in Patients with Huntington's Disease.

Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E, Smith AV, Bennett CF, Lane RM.

N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6.

PMID:
31059641
9.

Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Martín-Bastida A, Lao-Kaim NP, Roussakis AA, Searle GE, Xing Y, Gunn RN, Schwarz ST, Barker RA, Auer DP, Piccini P.

Brain. 2019 May 5. pii: awz120. doi: 10.1093/brain/awz120. [Epub ahead of print]

PMID:
31056699
10.

A qualitative study of active participation in sport and exercise for individuals with multiple sclerosis.

Smith M, Neibling B, Williams G, Birks M, Barker R.

Physiother Res Int. 2019 Apr 22:e1776. doi: 10.1002/pri.1776. [Epub ahead of print]

PMID:
31012221
11.

Parkinson disease and growth factors - is GDNF good enough?

Kirkeby A, Barker RA.

Nat Rev Neurol. 2019 Jun;15(6):312-314. doi: 10.1038/s41582-019-0180-6. No abstract available.

PMID:
30948845
12.

WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis.

Kaiser K, Gyllborg D, Procházka J, Salašová A, Kompaníková P, Molina FL, Laguna-Goya R, Radaszkiewicz T, Harnoš J, Procházková M, Potěšil D, Barker RA, Casado ÁG, Zdráhal Z, Sedláček R, Arenas E, Villaescusa JC, Bryja V.

Nat Commun. 2019 Apr 2;10(1):1498. doi: 10.1038/s41467-019-09298-4.

13.

Development of an automated underwater abrasion rig to determine galvanic effects during the growth and localised breakdown of surface films in CO2-containing solutions.

Barker R, Yazdi R, Hua Y, Jackson A, Ghanbarzadeh A, Huggan M, Charpentier T, Neville A.

Rev Sci Instrum. 2019 Mar;90(3):034101. doi: 10.1063/1.5064850.

PMID:
30927776
14.

Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.

Morrell L, Wordsworth S, Schuh A, Middleton MR, Rees S, Barker RW.

BMC Health Serv Res. 2019 Mar 28;19(1):198. doi: 10.1186/s12913-019-4039-8.

15.

Preferential adsorption to air-water interfaces: a novel cryoprotective mechanism for LEA proteins.

Yuen F, Watson M, Barker R, Grillo I, Heenan RK, Tunnacliffe A, Routh AF.

Biochem J. 2019 Apr 10;476(7):1121-1135. doi: 10.1042/BCJ20180901.

16.

'Staying strong on the inside and outside' to keep walking and moving around: Perspectives from Aboriginal people with Machado Joseph Disease and their families from the Groote Eylandt Archipelago, Australia.

Carr JJ, Lalara J, Lalara G, O'Hare G, Massey L, Kenny N, Pope KE, Clough AR, Lowell A, Barker RN.

PLoS One. 2019 Mar 11;14(3):e0212953. doi: 10.1371/journal.pone.0212953. eCollection 2019.

17.

Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease.

Horton MC, Nopoulos P, Nance M, Landwehrmyer GB, Barker RA, Squitieri F; REGISTRY Investigators of the European Huntington’s Disease Network, Burgunder JM, Quarrell O.

J Huntingtons Dis. 2019;8(2):181-193. doi: 10.3233/JHD-180306.

18.

Safety and efficacy of recovery-promoting drugs for motor function after stroke: A systematic review of randomized controlled trials.

Firth N, Barker RN, Hayward KS, Bernhardt J, Bellingan M, Gunnarsson R.

J Rehabil Med. 2019 May 13;51(5):319-330. doi: 10.2340/16501977-2536.

19.

Hyperosmotic stress induces cell-dependent aggregation of α-synuclein.

Fragniere AMC, Stott SRW, Fazal SV, Andreasen M, Scott K, Barker RA.

Sci Rep. 2019 Feb 19;9(1):2288. doi: 10.1038/s41598-018-38296-7.

20.

Stable isotope measurements to differentiate sources of monofluoroacetate in a blackmail case.

Van Hale R, Schofield M, Connor M, Barker R, Frew R.

Rapid Commun Mass Spectrom. 2019 May 15;33(9):839-847. doi: 10.1002/rcm.8416.

PMID:
30779226
21.

A low-cost and open-source platform for automated imaging.

Lien MR, Barker RJ, Ye Z, Westphall MH, Gao R, Singh A, Gilroy S, Townsend PA.

Plant Methods. 2019 Jan 28;15:6. doi: 10.1186/s13007-019-0392-1. eCollection 2019.

22.

Pathological Mechanisms and Clinical Aspects of GBA1 Mutation-Associated Parkinson’s Disease.

Stoker TB, Torsney KM, Barker RA.

In: Stoker TB, Greenland JC, editors. Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 Dec 21. Chapter 3.

23.

The Differential Diagnosis of Parkinson’s Disease.

Greenland JC, Barker RA.

In: Stoker TB, Greenland JC, editors. Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 Dec 21. Chapter 6.

24.

Financial interests of patient organisations contributing to technology assessment at England's National Institute for Health and Care Excellence: policy review.

Mandeville KL, Barker R, Packham A, Sowerby C, Yarrow K, Patrick H.

BMJ. 2019 Jan 16;364:k5300. doi: 10.1136/bmj.k5300.

25.

Variation in the transcriptome of different ecotypes of Arabidopsis thaliana reveals signatures of oxidative stress in plant responses to spaceflight.

Choi WG, Barker RJ, Kim SH, Swanson SJ, Gilroy S.

Am J Bot. 2019 Jan;106(1):123-136. doi: 10.1002/ajb2.1223. Epub 2019 Jan 15.

PMID:
30644539
26.

Disease-Modification in Huntington's Disease: Moving Away from a Single-Target Approach.

Jensen MP, Barker RA.

J Huntingtons Dis. 2019;8(1):9-22. doi: 10.3233/JHD-180320.

PMID:
30636742
27.

Ensuring safety in public playgrounds is everybody's business.

Barker RA, Eager D, Sharwood LN.

Med J Aust. 2019 Jan;210(1):9-11.e1. doi: 10.5694/mja18.00549. Epub 2018 Dec 28. No abstract available.

PMID:
30636314
28.

Pulmonary rehabilitation in bronchiectasis: a propensity-matched study.

Patel S, Cole AD, Nolan CM, Barker RE, Jones SE, Kon S, Cairn J, Loebinger M, Wilson R, Man WD.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801264. doi: 10.1183/13993003.01264-2018. Print 2019 Jan.

PMID:
30578381
29.

Platelet abnormalities in Huntington's disease.

Denis HL, Lamontagne-Proulx J, St-Amour I, Mason SL, Rowley JW, Cloutier N, Tremblay MÈ, Vincent AT, Gould PV, Chouinard S, Weyrich AS, Rondina MT, Barker RA, Boilard E, Cicchetti F.

J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):272-283. doi: 10.1136/jnnp-2018-318854. Epub 2018 Dec 19.

30.

The hunt for better treatments for Huntington's disease.

Barker R, Mason SL.

Lancet Neurol. 2019 Feb;18(2):131-133. doi: 10.1016/S1474-4422(18)30448-4. Epub 2018 Dec 15. No abstract available.

PMID:
30563777
31.

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.

White AJ, Wijeyekoon RS, Scott KM, Gunawardana NP, Hayat S, Solim IH, McMahon HT, Barker RA, Williams-Gray CH.

Front Neurol. 2018 Nov 20;9:946. doi: 10.3389/fneur.2018.00946. eCollection 2018.

32.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice.

Hall LS, Lennon CS, Hall AM, Urbaniak SJ, Vickers MA, Barker RN.

Haematologica. 2019 May;104(5):1074-1082. doi: 10.3324/haematol.2017.179424. Epub 2018 Dec 4.

33.

Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study.

Nolan CM, Maddocks M, Maher TM, Banya W, Patel S, Barker RE, Jones SE, George PM, Cullinan P, Man WD.

Eur Respir J. 2019 Feb 7;53(2). pii: 1801186. doi: 10.1183/13993003.01186-2018. Print 2019 Feb.

PMID:
30487200
34.

The pH-dependence of lipid-mediated antimicrobial peptide resistance in a model staphylococcal plasma membrane: A two-for-one mechanism of epithelial defence circumvention.

Rehal R, Gaffney PRJ, Hubbard ATM, Barker RD, Harvey RD.

Eur J Pharm Sci. 2019 Feb 1;128:43-53. doi: 10.1016/j.ejps.2018.11.017. Epub 2018 Nov 22.

PMID:
30471412
35.

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.

Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1279-1287. doi: 10.1136/jnnp-2018-318337. Epub 2018 Jul 25.

36.

Exploring causality of the association between smoking and Parkinson's disease.

Gallo V, Vineis P, Cancellieri M, Chiodini P, Barker RA, Brayne C, Pearce N, Vermeulen R, Panico S, Bueno-de-Mesquita B, Vanacore N, Forsgren L, Ramat S, Ardanaz E, Arriola L, Peterson J, Hansson O, Gavrila D, Sacerdote C, Sieri S, Kühn T, Katzke VA, van der Schouw YT, Kyrozis A, Masala G, Mattiello A, Perneczky R, Middleton L, Saracci R, Riboli E.

Int J Epidemiol. 2018 Nov 20. doi: 10.1093/ije/dyy230. [Epub ahead of print]

37.

Four priorities for new links between conservation science and accounting research.

Feger C, Mermet L, Vira B, Addison PFE, Barker R, Birkin F, Burns J, Cooper S, Couvet D, Cuckston T, Daily GC, Dey C, Gallagher L, Hails R, Jollands S, Mace G, Mckenzie E, Milne M, Quattrone P, Rambaud A, Russell S, Santamaria M, Sutherland WJ.

Conserv Biol. 2018 Nov 19. doi: 10.1111/cobi.13254. [Epub ahead of print]

38.

iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia.

Li L, Roh JH, Chang EH, Lee Y, Lee S, Kim M, Koh W, Chang JW, Kim HJ, Nakanishi M, Barker RA, Na DL, Song J.

Exp Neurobiol. 2018 Oct;27(5):350-364. doi: 10.5607/en.2018.27.5.350. Epub 2018 Oct 31.

39.

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.

Sugarman J, Barker RA, Kerridge I, Lysaght T, Pellegrini G, Sipp D, Tanner C.

Stem Cell Reports. 2018 Nov 13;11(5):1021-1025. doi: 10.1016/j.stemcr.2018.10.020.

40.

Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.

Lamontagne-Proulx J, St-Amour I, Labib R, Pilon J, Denis HL, Cloutier N, Roux-Dalvai F, Vincent AT, Mason SL, Williams-Gray C, Duchez AC, Droit A, Lacroix S, Dupré N, Langlois M, Chouinard S, Panisset M, Barker RA, Boilard E, Cicchetti F.

Neurobiol Dis. 2019 Apr;124:163-175. doi: 10.1016/j.nbd.2018.11.002. Epub 2018 Nov 5.

PMID:
30408591
41.

Cardiac rehabilitation services for people in rural and remote areas: an integrative literature review.

Field PE, Franklin RC, Barker RN, Ring I, Leggat PA.

Rural Remote Health. 2018 Nov;18(4):4738. doi: 10.22605/RRH4738. Epub 2018 Nov 7. Review.

42.

Social mission and medical school admissions - A medical student's response.

Barker R.

Med Teach. 2018 Nov 6:1. doi: 10.1080/0142159X.2018.1530745. [Epub ahead of print] No abstract available.

PMID:
30398081
43.

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis.

Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Jones JL, Clatworthy MR, Floto RA, Barker RA, Williams-Gray CH.

Front Neurol. 2018 Oct 16;9:870. doi: 10.3389/fneur.2018.00870. eCollection 2018.

44.

Ensuring safety in public playgrounds is everybody's business.

Barker RA, Eager D, Sharwood LN.

Med J Aust. 2018 Oct 29. [Epub ahead of print] No abstract available.

PMID:
30359559
45.

Emerging Treatment Approaches for Parkinson's Disease.

Stoker TB, Torsney KM, Barker RA.

Front Neurosci. 2018 Oct 8;12:693. doi: 10.3389/fnins.2018.00693. eCollection 2018. Review.

46.

In memory of Tom Isaacs: The epitomical mover and shaker.

Isaacs L, Barker R, Dowd E.

Eur J Neurosci. 2019 Feb;49(3):303. doi: 10.1111/ejn.14205. Epub 2018 Oct 31. No abstract available.

PMID:
30326157
47.

A snotty nose: more than just a cold.

Lim D, Barker R, Maltby K, George E.

BMJ Case Rep. 2018 Oct 12;2018. pii: bcr-2018-226686. doi: 10.1136/bcr-2018-226686. No abstract available.

48.

Towards biomimics of cell membranes: Structural effect of phosphatidylinositol triphosphate (PIP3) on a lipid bilayer.

Luchini A, Nzulumike ANO, Lind TK, Nylander T, Barker R, Arleth L, Mortensen K, Cárdenas M.

Colloids Surf B Biointerfaces. 2019 Jan 1;173:202-209. doi: 10.1016/j.colsurfb.2018.09.031. Epub 2018 Sep 22.

PMID:
30292933
49.

Outcome of cell suspension allografts in a patient with Huntington's disease.

Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, Barker RA, Cicchetti F.

Ann Neurol. 2018 Dec;84(6):950-956. doi: 10.1002/ana.25354. Epub 2018 Oct 25.

50.

Supplemental Content

Loading ...
Support Center